close

Medkart raises Rs 40 cr in Series A co-led by Alkemi, Insitor Partners

Having grown from scratch to 75 stores, predominantly in Gujarat, Medkart plans to use the funds for expansion to touch 250 stores by 2023

Vinay Umarji Ahmedabad
investment, investment bankers, brokers, investors, company, firms, board, directors, CEOs, management, funding, tech, economy, gdp, aif, alternative investment fund, capital, startups, tech, savings, money, cash, shares, funds, equity
Premium

One of the leading retail chains of generic medicines, Ahmedabad-based Medkart has raised Rs 40 crore in a Series A round, co-led by Alkemi Growth Capital and Insitor Partners.
Having grown from scratch to 75 stores, predominantly in Gujarat, apart from presence in Rajasthan and Maharashtra, Medkart plans to use the funds for expansion to touch 250 stores by 2023. Apart from Alkemi and Insitor, the round saw participation from angel investors including Prashant Poddar and other professionals from UAE and ex-CEO of IIFL Asset management. Mumbai based Investment Bank, Radix Capital Advisors acted as an exclusive financial advisor for Medkart.
Founded by Ankur Agarwal and Parasharan Chari in 2014, Medkart makes WHO GMP certified generic medicines at some of the most affordable rates available across its network of more than 75 stores.
Or

Also Read

Euro Cup 2021 round of 16 schedule, qualification scenarios, team standings

Euro 2020 round of 16 qualification scenarios for Portugal, Germany, Spain

F5 raises Rs 5 cr in pre-series A funding round led by Auxano Capital

Tekion raises $250mn in Series D funding round; valuation nearly triples

Meddo Health closes pre-series A round at $6 million led by SRI Capital

Test prep startup Toppersnote raises $1 mn in seed fund led by IPV

Startup Fasal raises $4 mn to expand business in India, southeast Asia

Despite farm laws' repeal, agritech investments may rise to $700 mn in FY22

E-commerce roll-up firm 10club acquires 3 gardening brands for unknown sum

Indian startups received $6.1 billion in funding in Q3CY21: Nasscom report

First Published: Nov 23 2021 | 4:09 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to read more on Business-Standard.com